Parallax Volatility Advisers
AGRX

Parallax Volatility Advisers’s Agile Therapeutics AGRX Stock Holding History

Parallax Volatility Advisers’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8
Closed -$47K – 3279
2020
Q3 		$47K Buy
+8
New +$45.9K ﹤0.01% 2859

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Parallax Volatility Advisers's AGRX Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Agile Therapeutics (AGRX) in Q4 2020, closing a stake of 8 shares — an estimated $47K sold.

Parallax Volatility Advisers first reported a position in AGRX in Q3 2020 and held it in 1 quarter. The position peaked at $47K in Q3 2020. 76 funds tracked by Wall St. Rank hold AGRX as of Q4 2020.

  • Parallax Volatility Advisers reported no remaining Agile Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 8 Agile Therapeutics shares in Q4 2020, an estimated $47K.
  • Parallax Volatility Advisers first reported a position in Agile Therapeutics in Q3 2020 and held it in 1 quarter.
  • Parallax Volatility Advisers's Agile Therapeutics position peaked at $47K in Q3 2020.
  • 76 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.